Invigor puts the SpotLite onto the SME market

|

Published 23-JUN-2016 11:02 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Following the updated release of their signature Shopping Ninja technology last week, the Australian data capture and analytics firm Invigor Group (ASX:IVO) has announced today the launch of their latest product, SpotLite.

Due for release in July 2016, SpotLite will enable small to medium sized retailers and brands to have access to a real time retail pricing system which can be accessed through a simple to use self-service portal or managed service.

The technology itself stems from the evolution of IVO’s market leading Insights range.

With SpotLite, IVO will be able to offer a wider range of solutions to segments previously not targeted by the company, expanding its potential client base by tens of thousands of SMEs.

Further to this expanded potential market base, the SpotLite technology can be used by international clients as well as Australian based SMEs.

In terms of pricing arrangements, there will be no lock-in contract for access to SpotLite, but rather flexible pay-as-you-go monthly plans, making the service more affordable and attractive for SMEs.

Invigor’s CEO, Gary Cohen spoke on the release of SpotLite, “Insights Retail has proven to be the pricing and market intelligence solution of choice of leading brands and retailers in Australia in consumer electronics and liquor industries. With SpotLite we can now address a large range of verticals from health & beauty, office supplies, pet foods, sporting goods, groceries, fashion, homewares and many others. We can also service the international market with our simple self-service portal. This is all based on our existing IP and proven solution designed to empower SMEs at an extremely affordable price.”

IVO seeks to add value to the market through its current products and projects in the pipeline, with tailored end-to-end solutions spanning sales, product management, business intelligence, marketing, advertising, content creation and distribution.

Customers of IVO are able to use the data offered to better understand the market, customers, competitors and demographics.

Groups that seek IVO’s services are retailers, brands, shopping centres and government bodies.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X